{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:42:19Z","timestamp":1786304539468,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier","isbn-type":[{"value":"9780443429538","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010567","name":"Secretar\u00eda de Estado de Ciencia,\nTecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.mcb.2026.04.005","type":"book-chapter","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:55:40Z","timestamp":1777172140000},"page":"105-121","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming T cell fate through antibody-mediated galectin-1 blockade"],"prefix":"10.1016","author":[{"given":"Roxana Kiyomi","family":"Mizutamari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"P\u00e9rez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Cagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo F.","family":"Hockl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Goin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Nahuel","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mcb.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.3748\/wjg.v19.i47.8831","article-title":"Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma","volume":"19","author":"Bacigalupo","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib2","article-title":"Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology","volume":"120","author":"Bannoud","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.immuni.2025.04.027","article-title":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","volume":"58","author":"Blidner","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/bs.mcb.2026.04.005_bib4","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells","volume":"118","author":"Cagnoni","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tibs.2016.11.003","article-title":"Translating the \u2018sugar code\u2019 into immune and vascular signaling programs","volume":"42","author":"Cerliani","year":"2017","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/bs.mcb.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","article-title":"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors","volume":"156","author":"Croci","year":"2014","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/0008-5472.CAN-12-2418","article-title":"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease","volume":"73","author":"Dalotto-Moreno","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/B:MCBI.0000049376.50242.7f","article-title":"Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1\/ERK, p38 MAP kinase and p70S6 kinase","volume":"267","author":"Fuertes","year":"2004","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.mcb.2026.04.005_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182041","article-title":"Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression","volume":"217","author":"Girotti","year":"2020","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.mcb.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/glycob\/cwu008","article-title":"Structural basis of redox-dependent modulation of galectin-1 dynamics and function","volume":"24","author":"Guardia","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.4049\/jimmunol.177.8.5328","article-title":"Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death","volume":"177","author":"Hernandez","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1038\/sj.onc.1211029","article-title":"Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells","volume":"27","author":"Hsieh","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj7552","article-title":"A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis","volume":"16","author":"Li","year":"2024","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.mcb.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.3892\/or.2016.4711","article-title":"Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-\u03baB signaling pathways","volume":"35","author":"Ma","year":"2016","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.mcb.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Mari\u00f1o","year":"2023","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.mcb.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2016.12.003","article-title":"Galectins: Emerging regulatory checkpoints linking tumor immunity and angiogenesis","volume":"45","author":"M\u00e9ndez-Huergo","year":"2017","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101913","article-title":"The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs","volume":"76","author":"Nardini","year":"2024","journal-title":"Seminars in Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1158\/1078-0432.CCR-18-3870","article-title":"Impact of galectins in resistance to anticancer therapies","volume":"26","author":"Navarro","year":"2020","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mcb.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00281-025-01047-8","article-title":"The sweet and the bitter sides of galectin-1 in immunity: Its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells","volume":"47","author":"Nov\u00e1k","year":"2025","journal-title":"Seminars in Immunopathology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib21","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2010-11-320481","article-title":"Viral induction and targeted inhibition of galectin-1 in EBV + posttransplant lymphoproliferative disorders","volume":"117","author":"Ouyang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2026.04.005_bib22","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2012-12-474569","article-title":"Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma","volume":"121","author":"Ouyang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2026.04.005_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/378736a0","article-title":"Apoptosis of T cells mediated by galectin-1","volume":"378","author":"Perillo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2026.04.005_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-020-09749-3","article-title":"Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities","volume":"24","author":"P\u00e9rez S\u00e1ez","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/bs.mcb.2026.04.005_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012391","article-title":"Tumor glyco-immunology, glyco-immunecheckpoints and immunotherapy","volume":"13","author":"Pinho","year":"2025","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/bs.mcb.2026.04.005_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.jbchem.a021762","article-title":"Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a \u03b2-galactoside-binding lectin","volume":"122","author":"Rabinovich","year":"1997","journal-title":"The Journal of Biochemistry"},{"key":"10.1016\/bs.mcb.2026.04.005_bib27","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.4049\/jimmunol.160.10.4831","article-title":"Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization","volume":"160","author":"Rabinovich","year":"1998","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","article-title":"Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer","volume":"36","author":"Rabinovich","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/bs.mcb.2026.04.005_bib29","article-title":"Glycan-binding proteins in immunity","author":"Rabinovich","year":"2025","journal-title":"Annual Reviews Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.mcb.2026.04.005_bib31","article-title":"Shaping hematopoietic cell ecosystems through galectin-glycan interactions","volume":"74","author":"Schattner","year":"2025","journal-title":"Seminars in Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: Targeting selectins, siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.mcb.2026.04.005_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ijc.26498","article-title":"Neuroblastoma triggers an immunoevasive program involving galectin\u20101\u2010dependent modulation of T cell and dendritic cell compartments","volume":"131","author":"Soldati","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.mcb.2026.04.005_bib34","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.4049\/jimmunol.180.5.3091","article-title":"Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion","volume":"180","author":"Stowell","year":"2008","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib35","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.carres.2006.04.028","article-title":"Synthesis of multivalent lactose derivatives by 1, 3-dipolar cycloadditions: selective galectin-1 inhibition","volume":"341","author":"Tejler","year":"2006","journal-title":"Carbohydrate Research"},{"key":"10.1016\/bs.mcb.2026.04.005_bib36","first-page":"235","article-title":"Galectin expression in cancer diagnosis and prognosis: a systematic review","volume":"1855","author":"Thijssen","year":"2015","journal-title":"Biochimica et Biophysica Acta: Reviews on Cancer"},{"key":"10.1016\/bs.mcb.2026.04.005_bib37","doi-asserted-by":"crossref","first-page":"15975","DOI":"10.1073\/pnas.0603883103","article-title":"Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy","volume":"103","author":"Thijssen","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2026.04.005_bib38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2007.01.006","article-title":"Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?","volume":"18","author":"Toscano","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/bs.mcb.2026.04.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.omtn.2019.10.029","article-title":"A DNA aptamer targeting galectin-1 as a novel immunotherapeutic strategy for for lung cancer","volume":"18","author":"Tsai","year":"2019","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/bs.mcb.2026.04.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101974","article-title":"An evolutionary perspective of the roles of galectins in pathogen recognition and immunity","volume":"79","author":"Vasta","year":"2025","journal-title":"Seminars in Immunology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2055-7_1","article-title":"Galectins: An ancient family of carbohydrate binding proteins with modern functions","volume":"2442","author":"Verkerke","year":"2022","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.mcb.2026.04.005_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424051122","article-title":"Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells","volume":"122","author":"Vinaixa","year":"2025","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.mcb.2026.04.005_bib45","article-title":"Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis","volume":"121","author":"Wang","year":"2024","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1873-3468.14047","article-title":"Galectin\u20101-RNA interaction map reveals potential regulatory roles in angiogenesis","volume":"595","author":"Wei","year":"2021","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.mcb.2026.04.005_bib47","article-title":"Galectin-1-induced tumor associated macrophages repress antitumor immunity in hepatocellular carcinoma through recruitment of tregs","volume":"12","author":"Yu","year":"2025","journal-title":"Advanced Science"},{"key":"10.1016\/bs.mcb.2026.04.005_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death & Disease"}],"container-title":["Methods in Cell Biology","Cell Death - Part D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X26001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X26001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:20:42Z","timestamp":1786303242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X26001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443429538"],"references-count":48,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2026.04.005","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}